Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): A pooled analysis

Gynecologic Oncology

Volumn 121, Issue 1, 2011, Pages 135-142

  Hou, June ^a   Goldberg, Gary L ^a   Qualls, Clifford R ^b   Kuo, Dennis Y S ^a   Forman, Aliza ^a   Smith, Harriet O ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Adenocarcinoma in situ; Cervical carcinoma; Histology; Microinvasive adenocarcinoma

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYSTEMATIC REVIEW; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION;

ADENOCARCINOMA; ADULT; AGE FACTORS; CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; SEER PROGRAM; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 79952814026     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.11.036     Document Type: Article

References (77)

1. Hopkins MP, Roberts JA, Schmidt RW. Cervical adenocarcinoma in situ. Obstet Gynecol 1988;71:842-4.
2. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002;359: 1085-92. (Pubitemid 34270731)
3. Lacey Jr JV, Brinton LA, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2000;77:149-54. (Pubitemid 30217318)
4. Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987;47:1706-11. (Pubitemid 17044508)
5. Lacey Jr JV,Swanson CA, Brinton LA, Altekruse SF, BarnesWA,Gravitt PE, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003;98:814-21. (Pubitemid 36959279)
6. Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodill A, Green J, Peto J, Plummer M, Sweetland S. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481-95.
7. Zaino RJ. Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2002;21: 314-26.
8. Shipman SD, Bristow RE. Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix. Curr Opin Oncol 2001;13:394-8. (Pubitemid 32785294)
9. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103-4.
10. Pecorelli S. Corrigendum to "Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium": [International Journal of Gynecology and Obstetrics (2009) 105: 103-104]. International Journal of Gynecology & Obstetrics 108: 176-176
11. Mutch DG. The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas. Gynecol Oncol 2009;115:325-8.
12. Smith HO, Padilla LA. Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear: will cytologic screening for adenocarcinoma in situ reduce incidence rates for adenocarcinoma. Cancer 2002;96:319-22. (Pubitemid 37356004)
13. Case AS, Rocconi RP, Straughn Jr JM, Wang W, Roark K, Waltman EE, et al. Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes. Obstet Gynecol 2006;108:1369-74. (Pubitemid 44901009)
14. Herzog TJ, Monk BJ. Reducing the burden of glandular carcinomas of the uterine cervix. Am J Obstet Gynecol 2007;197:566-71. (Pubitemid 350166265)
15. Cohn DE, Morrison CD, Zanagnolo VL, Goist MM, Copeland LJ. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins. Gynecol Oncol 2005;98:158-60. (Pubitemid 40826435)
16. Singh P, Scurry J, Proietto A. Lethal endometrial recurrence after cone biopsy for microinvasive cervical adenocarcinoma. J Obstet Gynaecol Res 2008;34:413-7. (Pubitemid 351832345)
17. Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol 1996;88: 82-6. (Pubitemid 26197282)
18. Berek JS, Hacker NF, Fu YS, Sokale JR, Leuchter RC, Lagasse LD. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 1985;65:46-52. (Pubitemid 15187628)
19. Qizilbash AH. In-situ andmicroinvasive adenocarcinoma of the uterine cervix. Aclinical, cytologic and histologic study of 14 cases. Am J Clin Pathol 1975;64:155-70.
20. Fu YS, Berek JS, Hilborne LH. Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix. Appl Pathol 1987;5:47-56. (Pubitemid 17110741)
21. Ostor A, Rome R, Quinn M. Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol 1997;89:88-93. (Pubitemid 27024474)
22. Ostor AG. Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2000;19:29-38. (Pubitemid 30010640)
23. Ostor AG, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol 2000;79:207-10.
24. Ostor AG, Rome RM. Micro-invasive squamous cell carcinoma of the cervix: a clinico-pathologic study of 200 cases with long-term follow-up. Int J Gynecol Cancer 1994;4:257-64.
25. Teshima S, Shimosato Y, Kishi K, Kasamatsu T, Ohmi K, Uei Y. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis. Cancer 1985;56:167-72.
26. Kaku T, Kamura T, Sakai K, Amada S, Kobayashi H, Shigematsu T, et al. Early adenocarcinoma of the uterine cervix. Gynecol Oncol 1997;65:281-5. (Pubitemid 27216941)
27. Van den Broek NR, Lopes AD, Ansink A, Monaghan JM. " Microinvasive" adenocarcinoma of the cervix implanting in an episiotomy scar. Gynecol Oncol 1995;59:297-9.
28. Kurian K, al-Nafussi A. Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: a study of 121 cases. J Clin Pathol 1999;52:112-7. (Pubitemid 29062345)
29. Smith HO, Qualls CR, Romero AA, Webb JC, Dorin MH, Padilla LA, et al. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix? Gynecol Oncol 2002;85:229-41.
30. Webb JC, Key CR, Qualls CR, Smith HO. Population-based study of microinvasive adenocarcinoma of the uterine cervix. Obstet Gynecol 2001;97:701-6.
31. Jones WB, Mercer GO, Lewis Jr JL, Rubin SC, Hoskins WJ. Early invasive carcinoma of the cervix. Gynecol Oncol 1993;51:26-32. (Pubitemid 23339259)
32. Sachs H, Ikeda J, Brachetti AK. Microinvasive adenocarcinoma and adenocarcinoma in situ of the cervix uteri. Med Welt 1975;26:1181-3.
33. Burghardt E. Pathology of preclinical invasive carcinoma of cervix. (Microinvasive and occult invasive carcinoma). In: Fu Y, Reagan JW, Bennington JL, editors. Pathology of the Uterine Cervix, Vagina, and Vulva. Philadelphia: Saunders; 1989. p. 447-9.
34. Schumacher TN, Kantesaria DV, Serreze DV, Roopenian DC, Ploegh HL. Transporters from H-2b, H-2d, H-2s, H-2k, and H-2g7 (NOD/Lt) haplotype translocate similar sets of peptides. Proc Natl Acad Sci USA 1994;91:13004-8.
35. Krimmenau R. Adenocarcinoma in situ, beginning adenocarcinomatous invasion and microcarcinoma adenomatosum. Geburtshilfe Frauenheilkd 1966;26:1297-305.
36. Nicklin JL, Perrin LC, Crandon AJ, Ward BG. Microinvasive adenocarcinoma of the cervix. Aust N Z J Obstet Gynaecol 1999;39:411-3.
37. Werner R,Waidecker F. Adenocarcinoma in situ andmicroinvasive adenocarcinoma of the cervix uteri (author's transl). Österr Z Onkol 1975;2:154-7.
38. Nakajima H. Clinicopathological study on early adenocarcinoma. Nagasaki Med J 1983;58:218-33.
39. Piura B, Dgani R, Yanai-Inbar I, Cohen Y, Glezerman M. Adenocarcinoma of the uterine cervix: a study of 37 cases. J Surg Oncol 1996;61:249-55. (Pubitemid 26117116)
40. Matsukuma K, Tsukamoto N, Kaku T, Matsumura M, Toki N, Toh N, et al. Early adenocarcinoma of the uterine cervix - its histologic and immunohistologic study. Gynecol Oncol 1989;35:38-43. (Pubitemid 19257742)
41. Ceballos KM, Shaw D, Daya D. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis. Am J Surg Pathol 2006;30:370-4. (Pubitemid 43740170)
42. Sevin BU, Lu Y, Bloch DA, Nadji M, Koechli OR, Averette HE. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 1996;78:1438-46. (Pubitemid 26317864)
43. Benedet JL, Anderson GH. Stage IA carcinoma of the cervix revisited. Obstet Gynecol 1996;87:1052-9. (Pubitemid 26159410)
44. Kennedy AW, el Tabbakh GH, Biscotti CV, Wirth S. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 1995;58:274-7.
45. Nagarsheth NP, Maxwell GL, Bentley RC, Rodriguez G. Bilateral pelvic lymph node metastases in a case of FIGO stage IA(1) adenocarcinoma of the cervix. Gynecol Oncol 2000;77:467-70.
46. Elliott P, Coppleson M, Russell P, Liouros P, Carter J, MacLeod C, et al. Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer 2000;10:42-52. (Pubitemid 30219477)
47. Kasamatsu T, Okada S, Tsuda H, Shiromizu K, Yamada T, Tsunematsu R, et al. Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment. Gynecol Oncol 2002;85:327-32. (Pubitemid 34522994)
48. Matthews CM, Burke TW, Tornos C, Eifel PJ, Atkinson EN, Stringer CA, et al. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol 1993;49:19-23. (Pubitemid 23148576)
49. Covens A, Kirby J, Shaw P, Chapman W, Franseen E. Prognostic factors for relapse and pelvic lymph node metastases in early stage I adenocarcinoma of the cervix. Gynecol Oncol 1999;74:423-7. (Pubitemid 29439883)
50. Utsugi K, Shimizu Y, Akiyama F, Hasumi K. Is the invasion depth in millimeters valid to determine the prognosis of early invasive cervical adenocarcinoma? A case of recurrent FIGO stage IA1 cervical adenocarcinoma. Gynecol Oncol 2001;82: 205-7. (Pubitemid 32634979)
51. Erzen M, Mozina A, Bertole J, Syrjanen K. Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 2002;101:185-91. (Pubitemid 34163267)
52. Abdulhathi MB, Al-Salam S, Kassis A, Ghazal-Aswad S. Unusual presentation of cervical cancer as advanced ovarian cancer. Arch Gynecol Obstet 2007;276: 387-90. (Pubitemid 47397560)
53. Brown JV, Fu YS, Berek JS. Ovarian metastases are rare in stage I adenocarcinoma of the cervix. Obstet Gynecol 1990;76:623-6. (Pubitemid 20322063)
54. Delotte J, Ferron G, Kuei TL, Mery E, Gladieff L, Querleu D. Laparoscopic management of an isolated ovarian metastasis on a transposed ovary in a patient treated for stage IB1 adenocarcinoma of the cervix. J Minim Invasive Gynecol 2009;16:106-8.
55. Khunamornpong S, Suprasert P, Chiangmai WN, Siriaunkgul S. Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand. Int J Gynecol Cancer 2006;16(Suppl 1):132-8.
56. Mann WJ, Chumas J, Amalfitano T, Westermann C, Patsner B. Ovarian metastases from stage IB adenocarcinoma of the cervix. Cancer 1987;60:1123-6. (Pubitemid 17157231)
57. Nakanishi T, Wakai K, Ishikawa H, Nawa A, Suzuki Y, Nakamura S, et al. A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol 2001;82:504-9. (Pubitemid 32826451)
58. Natsume N, Aoki Y, Kase H, Kashima K, Sugaya S, Tanaka K. Ovarian metastasis in stage IB and II cervical adenocarcinoma. Gynecol Oncol 1999;74:255-8. (Pubitemid 29377222)
59. Ronnett BM, Yemelyanova AV, Vang R, Gilks CB, Miller D, Gravitt PE, et al. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol 2008;32: 1835-53.
60. Sutton GP, Bundy BN, Delgado G, Sevin BU, Creasman WT, Major FJ, et al. Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1992;166:50-3.
61. Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2003;89:314-7. (Pubitemid 36457882)
62. Young RH, Gersell DJ, Roth LM, Scully RE. Ovarian metastases from cervical carcinomas other than pure adenocarcinomas. A report of 12 cases. Cancer 1993;71:407-18. (Pubitemid 23021229)
63. Bisseling KC, Bekkers RL, Rome RM, Quinn MA. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature. Gynecol Oncol 2007;107:424-30. (Pubitemid 350160852)
64. Salani R, Puri I, Bristow RE. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status. Am J Obstet Gynecol 2009;200(182):e1-5.
65. Simon NL, Gore H, Shingleton HM, Soong SJ, Orr Jr JW, Hatch KD. Study of superficially invasive carcinoma of the cervix. Obstet Gynecol 1986;68:19-24. (Pubitemid 16090832)
66. Andersen ES, Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinicopathologic study of 36 cases. Gynecol Oncol 1989;35:1-7. (Pubitemid 19257736)
67. Rollason TP, Cullimore J, Bradgate MG. A suggested columnar cell morphological equivalent of squamous carcinoma in situ with early stromal invasion. Int J Gynecol Pathol 1989;8:230-6. (Pubitemid 19202341)
68. Angel C, DuBeshter B, Lin JY. Clinical presentation and management of stage I cervical adenocarcinoma: a 25 year experience. Gynecol Oncol 1992;44:71-8.
69. Kaspar HG, Dinh TV, Doherty MG, Hannigan EV, Kumar D. Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix. Obstet Gynecol 1993;81:296-300. (Pubitemid 23050174)
70. Schorge JO, Lee KR, Flynn CE, Goodman A, Sheets EE. Stage IA1 cervical adenocarcinoma: definition and treatment. Obstet Gynecol 1999;93:219-22. (Pubitemid 29068096)
71. Schorge JO, Lee KR, Sheets EE. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report. Gynecol Oncol 2000;78:217-20.
72. Lee KR, Flynn CE. Early invasive adenocarcinoma of the cervix. Cancer 2000;89: 1048-55.
73. Balega J, Michael H, Hurteau J, Moore DH, Santiesteban J, Sutton GP, et al. The risk of nodal metastasis in early adenocarcinoma of the uterine cervix. Int J Gynecol Cancer 2004;14:104-9. (Pubitemid 38280631)
74. Hirai Y, Takeshima N, Tate S, Akiyama F, Furuta R, Hasumi K. Early invasive cervical adenocarcinoma: its potential for nodal metastasis or recurrence. BJOG 2003;110: 241-6. (Pubitemid 36298905)
75. Poynor EA, Marshall D, Sonoda Y, Slomovitz BM, Barakat RR, Soslow RA. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization. Gynecol Oncol 2006;103:960-5. (Pubitemid 44821322)
76. Yahata T, Numata M, Kashima K, Sekine M, Fujita K, Yamamoto T, et al. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy. Gynecol Oncol 2008;109:49-52.
77. Jones MW, Silverberg SG, Kurman RJ. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases. Int J Gynecol Pathol 1993;12:1-7. (Pubitemid 23013905)